Tailwinds' Take: patents show the uniqueness of INKmune, which is set to start two clinical trials this year. INMB is one of the most exciting opportunities we see in the marketplace. LA JOLLA, Calif., April 22, 2020 (GLOBE NEWSWIRE) --...
The Augmented World Expo begins May 30, 2018. The talk of the show will be rapid adoption of Augmented Reality in Enterprise. Companies big and small across the world are starting to unlock improvements in workforce safety and productivity...
This was a very hectic week in the market, with major swings in the indexes and in our universe of smaller companies. Earnings season for most smaller companies is the first two weeks of August, which creates ample reasons...
Tailwinds' Take: Voriconazole is a generic liquid or tablet that is ingested for diseases like IPA, which start in the lungs. Having a direct to the lung inhalation would be more effective and also reduce the dosage required. This...
Tailwinds' Take: This is a major milestone for 3DS as PRECISE is the first ever large-scale multi-center study focused on men with a clinical suspicion of prostate cancer. It serves to validate their diagnostic technology among potential prostate cancer patients, a huge...
SAN JOSE, Calif.--(BUSINESS WIRE)-- Summit Wireless Technologies, Inc (NASDAQ: WISA), a leading provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems and founding member of the WiSA Association, today announced the pricing of its...
ROCHESTER, N.Y., March 12, 2018 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets, is pleased to announce that the company...
Tailwinds' Take: ImageWare has started winning business, but it will take a while for revenues to ramp. This bandaid financing is likely not the last needed before they achieve positive cash flows, however more positive traction in terms of...
SAN JOSE, Calif., March 2, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data related to Anixa's recently launched Cchek™ Prostate Cancer...
Tailwinds' Take: ITUS has a potentially game-changing diagnostic here. Dr. Kumar's comments about benign studies are quite foreshadowing. We can expect to hear more about this in the future. Also note the multi-billion valuations on liquid biopsy diagnostic companies;...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.